References
- TauscheAKJansenTLSchroderHEBornsteinSRAringerMMuller-LadnerUGout – current diagnosis and treatmentDtsch Arztebl Int200910634–3554955519795010
- TerkeltaubRUpdate on gout: new therapeutic strategies and optionsNat Rev Rheumatol201061303820046204
- NeogiTClinical practice. GoutN Engl J Med2011364544345221288096
- BeckerMASchumacherHRBenjaminKLQuality of life and disability in patients with treatment-failure goutJ Rheumatol20093651041104819332629
- LeeSJHirschJDTerkeltaubRPerceptions of disease and health-related quality of life among patients with goutRheumatology (Oxford)200948558258619307257
- RoddyEZhangWDohertyMIs gout associated with reduced quality of life? A case-control studyRheumatology (Oxford)20074691441144417586863
- ChandratrePRoddyEClarsonLRichardsonJHiderSLMallenCDHealth-related quality of life in gout: a systematic reviewRheumatology (Oxford)201352112031204023934311
- WuEQForsytheAGuerinAYuAPLatremouille-ViauDTsanevaMComorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapyAm J Ther2012196e157e16621317625
- WuEQPatelPAYuAPDisease-related and all-cause health care costs of elderly patients with goutJ Manag Care Pharm200814216417518331118
- ZhuYPandyaBJChoiHKPrevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008Arthritis Rheum201163103136314121800283
- HamburgerMBarafHSAdamsonTC3rd2011 Recommendations for the diagnosis and management of gout and hyperuricemiaPostgrad Med20111236 Suppl 133622156509
- KhannaDKhannaPPFitzgeraldJD2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritisArthritis Care Res (Hoboken)201264101447146123024029
- KhannaDFitzgeraldJDKhannaPP2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care Res (Hoboken)201264101431144623024028
- HarroldLRAndradeSEBriesacherBThe dynamics of chronic gout treatment: medication gaps and return to therapyAm J Med20101231545920102992
- HarroldLRAndradeSEBriesacherBAAdherence with urate-lowering therapies for the treatment of goutArthritis Res Ther2009112R4619327147
- RiedelAANelsonMJoseph-RidgeNWallaceKMacDonaldPBeckerMCompliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claimsJ Rheumatol20043181575158115290738
- SolomonDHAvornJLevinRBrookhartMAUric acid lowering therapy: prescribing patterns in a large cohort of older adultsAnn Rheum Dis200867560961317728328
- BarbosaCDBalpMMKulichKGermainNRofailDA literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePatient Prefer Adherence20126394822272068
- DelestrasSRoustitMBedouchPComparison between two generic questionnaires to assess satisfaction with medication in chronic diseasesPLoS One201382e5624723437104
- BidermanANoffEHarrisSBFriedmanNLevyATreatment satisfaction of diabetic patients: what are the contributing factors?Fam Pract200926210210819254969
- NettRBTiseoPJAlmasMSikesCRPatient satisfaction with eletriptan in the acute treatment of migraine in primary careInt J Clin Pract200761101677168517877653
- American Medical AssociationGetting the most for our health care dollars Available from: http://www.ama-assn.org/resources/doc/health-care-costs/prevention-and-wellness.pdfAccessed September 11, 2013
- HirschJDLeeSJTerkeltaubREvaluation of an instrument assessing influence of Gout on health-related quality of lifeJ Rheumatol200835122406241418925685
- SpaetgensBvan der LindenSBoonenAThe Gout Assessment Questionnaire 2.0: cross-cultural translation into Dutch, aspects of validity and linking to the International Classification of Functioning, Disability and HealthRheumatology (Oxford)201453467868524357808
- AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
- JobanputraPMaggsFDeemingAA randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 yearsBMJ Open201226e001395
- LinHYChengTTWangJHEtoricoxib improves pain, function and quality of life: results of a real-world effectiveness trialInt J Rheum Dis201013214415020536599
- Takeda Pharmaceuticals America IUloric (febuxostat). Prescribing information2013 Available from: http://www.uloric.com/Accessed September 17, 2013
- Census Regions and Divisions of the United StatesUS Census Bureau http://www2.census.gov/geo/pdfs/maps-data/maps/reference/us_regdiv.pdfAccessed May 22, 2015
- AtkinsonMJKumarRCappelleriJCHassSLHierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM version II) among outpatient pharmacy consumersValue Health20058Suppl 1S9S2416336491
- ColwellHHHuntBJPastaDJPaloWAMathiasSDJoseph-RidgeNGout Assessment Questionnaire: initial results of reliability, validity and responsivenessInt J Clin Pract200660101210121716911575
- MaruishMEUser’s Manual for the SF-12v2 Health Survey3rd edLincoln (RI)QualityMetric Inc2012
- WareJJrKosinskiMKellerSDA 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validityMed Care19963432202338628042
- BMJCorrelation and regression Available from: http://www.bmj.com/about-bmj/resources-readers/publications/statistics-square-one/11-correlation-and-regressionAccessed December 6, 2013
- HirschJDTerkeltaubRKhannaDGout disease-specific quality of life and the association with gout characteristicsPatient Relat Outcome Meas201020101821686040
- KhannaDSarkinAJKhannaPPMinimally important differences of the Gout Impact Scale in a randomized controlled trialRheumatology (Oxford)20115071331133621372003
- KhannaPPPerez-RuizFMaranianPKhannaDLong-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic goutRheumatology (Oxford)201150474074521147824
- KhannaPPNukiGBardinTTophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional surveyHealth Qual Life Outcomes20121011722999027
- SinghJATaylorWJSimonLSPatient-reported outcomes in chronic gout: a report from OMERACT 10J Rheumatol20113871452145721724715